• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635WU50310
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Stroke/CVA (1770); Thrombosis/Thrombus (4440)
Date of Event 03/03/2026
Type of Reportable Event Serious Injury
Event or Problem Description
Reported via patient call center.It was reported a cerebral vascular accident (cva) and thrombosis occurred.A left atrial appendage (laa) closure procedure was performed and a 31mm watchman flx closure device was implanted.At an unknown date post index procedure, the patient reported having a cva and a thrombus was found to be attached to the closure device.The physicians started the patient on eliquis in response to the thrombus and will have the patient take another test in three (3) months to see if the thrombus has dissolved.
 
Additional Manufacturer Narrative
B3: bsc aware date used as event date, as it is unknown.
 
Additional Manufacturer Narrative
The device was not returned for analysis as the device remains implanted; therefore, a technical analysis could not be performed.It was confirmed this device met manufacturing specification prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Event or Problem Description
Reported via patient call center.It was reported a cerebral vascular accident (cva) and thrombosis occurred.A left atrial appendage (laa) closure procedure was performed and a 31mm watchman flx closure device was implanted.At an unknown date post index procedure, the patient reported having a cva and a thrombus was found to be attached to the closure device.The physicians started the patient on eliquis in response to the thrombus and will have the patient take another test in three (3) months to see if the thrombus has dissolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX?
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key24546027
Report Number2124215-2026-12858
Device Sequence Number12177957
Product Code NGV
UDI-Device Identifier08714729860518
UDI-Public(01)08714729860518(17)250907(10)30111372
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/07/2025
Device Model NumberM635WU50310
Device Catalogue NumberM635WU50310
Device Lot Number0030111372
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/03/2026
Supplement Date Received by Manufacturer04/17/2026
Initial Report FDA Received Date03/09/2026
Supplement Report FDA Received Date04/24/2026
Date Device Manufactured09/08/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age72 YR
Patient SexMale
-
-